PHAT
Price
$9.35
Change
-$0.41 (-4.20%)
Updated
Jun 26, 01:35 PM (EDT)
Capitalization
668.82M
42 days until earnings call
TNFA
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Jun 26, 01:43 PM (EDT)
Capitalization
1.95M
Interact to see
Advertisement

PHAT vs TNFA

Header iconPHAT vs TNFA Comparison
Open Charts PHAT vs TNFABanner chart's image
Phathom Pharmaceuticals
Price$9.35
Change-$0.41 (-4.20%)
Volume$915
Capitalization668.82M
TNF Pharmaceuticals
Price$0.13
Change-$0.01 (-7.14%)
Volume$6.7K
Capitalization1.95M
PHAT vs TNFA Comparison Chart in %
Loading...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHAT vs. TNFA commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHAT is a Buy and TNFA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (PHAT: $9.58 vs. TNFA: $0.14)
Brand notoriety: PHAT and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHAT: 22% vs. TNFA: 139%
Market capitalization -- PHAT: $668.82M vs. TNFA: $1.95M
PHAT [@Biotechnology] is valued at $668.82M. TNFA’s [@Biotechnology] market capitalization is $1.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHAT’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • PHAT’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, both PHAT and TNFA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHAT’s TA Score shows that 4 TA indicator(s) are bullish while TNFA’s TA Score has 3 bullish TA indicator(s).

  • PHAT’s TA Score: 4 bullish, 4 bearish.
  • TNFA’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both PHAT and TNFA are a good buy in the short-term.

Price Growth

PHAT (@Biotechnology) experienced а -12.11% price change this week, while TNFA (@Biotechnology) price change was -1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

PHAT is expected to report earnings on Aug 07, 2025.

TNFA is expected to report earnings on Apr 11, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($669M) has a higher market cap than TNFA($1.95M). PHAT YTD gains are higher at: 17.980 vs. TNFA (-88.035). TNFA has higher annual earnings (EBITDA): -8.35M vs. PHAT (-272.12M). PHAT has more cash in the bank: 212M vs. TNFA (5.88M). TNFA has less debt than PHAT: TNFA (2.68K) vs PHAT (204M). PHAT has higher revenues than TNFA: PHAT (81.9M) vs TNFA (0).
PHATTNFAPHAT / TNFA
Capitalization669M1.95M34,273%
EBITDA-272.12M-8.35M3,260%
Gain YTD17.980-88.035-20%
P/E RatioN/AN/A-
Revenue81.9M0-
Total Cash212M5.88M3,606%
Total Debt204M2.68K7,617,625%
FUNDAMENTALS RATINGS
TNFA: Fundamental Ratings
TNFA
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PHATTNFA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
84%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSVSX9.18N/A
N/A
MassMutual Small Company Val R5
DODWX15.53N/A
N/A
Dodge & Cox Global Stock I
KSDVX16.08N/A
N/A
Keeley Small Cap Dividend Value A
DDVCX13.64-0.07
-0.51%
Macquarie Value C
VLEOX58.77-0.55
-0.93%
Value Line Small Cap Opportunities Inv

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TNFA. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TNFA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
-1.84%
TNFA - PHAT
39%
Loosely correlated
-1.57%
ATRA - PHAT
36%
Loosely correlated
-0.50%
PRME - PHAT
35%
Loosely correlated
-1.63%
RGNX - PHAT
35%
Loosely correlated
-0.23%
URGN - PHAT
35%
Loosely correlated
-0.51%
More

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with COGT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
-1.57%
COGT - TNFA
39%
Loosely correlated
-2.35%
PHAT - TNFA
39%
Loosely correlated
-1.84%
TVGN - TNFA
36%
Loosely correlated
-0.85%
LRMR - TNFA
32%
Poorly correlated
+8.70%
BPMC - TNFA
29%
Poorly correlated
-0.12%
More